---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-019143"
form_type: "8-K"
ticker: "PVLA"
cik: "0001583648"
company_name: "PALVELLA THERAPEUTICS, INC."
filed_at: "2026-02-24T23:59:59+00:00"
generated_at: "2026-05-16T00:48:03.441227+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "medium"
source: SEC EDGAR
---

# Palvella Therapeutics reports preliminary Dec 31, 2025 cash of $55.9M

## Summary
- Preliminary unaudited cash, cash equivalents and marketable securities as of Dec 31, 2025: $55.9 million.
- Amount subject to change upon completion of financial close procedures; not audited by Ernst & Young.
- No other financial results provided; full year 2025 results pending.

## SEC filing metadata
- accession: 0001104659-26-019143
- form_type: 8-K
- ticker: PVLA
- cik: 0001583648
- company_name: PALVELLA THERAPEUTICS, INC.
- filed_at: 2026-02-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: medium
- sec_items: 2.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583648/000110465926019143/0001104659-26-019143-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583648/000110465926019143/tm267157d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-019143
- JSON: https://secwatch.observer/filing/0001104659-26-019143.json
- Plain text: https://secwatch.observer/filing/0001104659-26-019143.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.